Abstract
Retinoblastoma and Wilms’ tumor represent two childhood tumors with both sporadic and familial forms. Delineation of the molecular etiology of these cancers identified the retinoblastoma gene Rb as the first example of a tumor suppressor gene and provided the first example of imprinting and cancer predisposition in Wilms’ tumor. In this chapter, we review the clinical features and genetics of these two disorders and the implications for management, early detection and potential prevention of these disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Devesa SS (1975) The incidence of retinoblastoma. Am J Ophthalmol 80(2):263–265
Francois J, Matton MT, De Bie S, Tanaka Y, Vandenbulcke D (1975) Genesis and genetics of retinoblastoma. Ophthalmologica 170(5):405–425
Mahoney MC, Burnett WS, Majerovics A, Tanenbaum H (1990) The epidemiology of ophthalmic malignancies in New York State. Ophthalmology 97(9):1143–1147
Vogel F (1979) Genetics of retinoblastoma. Hum Genet 52(1): 1–54
Abramson DH, Ellsworth RM, Grumbach N, Kitchin FD (1985) Retinoblastoma: survival, age at detection and comparison 1914–1958, 1958–1983. J Pediatr Ophthalmol Strabismus 22(6): 246–250
Abramson DH (1999) Second nonocular cancers in retinoblastoma: a unified hypothesis. The Franceschetti Lecture. Ophthalmic Genet 20(3):193–204
Grabowski EF, Abramson DH (1987) Intraocular and extraocular retinoblastoma. Hematol Oncol Clin North Am 1(4):721–735
Zimmerman LE, Burns RP, Wankum G, Tully R, Esterly JA (1982) Trilateral retinoblastoma: ectopic intracranial retinoblastoma associated with bilateral retinoblastoma. J Pediatr Ophthalmol Strabismus 19(6):320–325
Grabowski EF (2006) Intraocular and extraocular retinoblastoma. In: Burg FD, Polin RA, Ingelfinger JR, Wald ER (eds) Current pediatric therapy, 18th edn. WB Saunders Co, Philadelphia, pp 1101–1105
Friend SH, Bernards R, Rogelj S et al (1986) A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323(6089):643–646
Mukai S (1993) Molecular genetic diagnosis of retinoblastoma. Informa Healthcare 8:292–299
Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68(4):820–823
Fung YK, Murphree AL, T’Ang A, Qian J, Hinrichs SH, Benedict WF (1987) Structural evidence for the authenticity of the human retinoblastoma gene. Science 236(4809):1657–1661
Lee WH, Bookstein R, Hong F, Young LJ, Shew JY, Lee EY (1987) Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 235(4794):1394–1399
Klutz M, Horsthemke B, Lohmann DR (1999) RB1 gene mutations in peripheral blood DNA of patients with isolated unilateral retinoblastoma. Am J Hum Genet 64(2):667–668
Lohmann DR, Gerick M, Brandt B et al (1997) Constitutional RB1-gene mutations in patients with isolated unilateral retinoblastoma. Am J Hum Genet 61(2):282–294
Shimizu T, Toguchida J, Kato MV, Kaneko A, Ishizaki K, Sasaki MS (1994) Detection of mutations of the RB1 gene in retinoblastoma patients by using exon-by-exon PCR-SSCP analysis. Am J Hum Genet 54(5):793–800
De Falco G, Giordano A (2006) pRb2/p130: a new candidate for retinoblastoma tumor formation. Oncogene 25(38):5333–5340
Toguchida J, McGee TL, Paterson JC et al (1993) Complete genomic sequence of the human retinoblastoma susceptibility gene. Genomics 17(3):535–543
DeCaprio JA, Ludlow JW, Figge J et al (1988) SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54(2):275–283
Dyson N, Howley PM, Munger K, Harlow E (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243(4893):934–937
Whyte P, Buchkovich KJ, Horowitz JM et al (1988) Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334(6178):124–129
Lee JO, Russo AA, Pavletich NP (1998) Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Nature 391(6670):859–865
Bremner R, Du DC, Connolly-Wilson MJ et al (1997) Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma. Am J Hum Genet 61(3):556–570
Shen WJ, Kim HS, Tsai SY (1995) Stimulation of human insulin receptor gene expression by retinoblastoma gene product. J Biol Chem 270(35):20525–20529
Dyson N (1998) The regulation of E2F by pRB-family proteins. Genes Dev 12(15):2245–2262
Harbour JW, Dean DC (2000) Rb function in cell-cycle regulation and apoptosis. Nat Cell Biol 2(4):E65–E67
Chen PL, Scully P, Shew JY, Wang JY, Lee WH (1989) Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58(6): 1193–1198
Stein GH, Beeson M, Gordon L (1990) Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts. Science 249(4969):666–669
Chow KN, Dean DC (1996) Domains A and B in the Rb pocket interact to form a transcriptional repressor motif. Mol Cell Biol 16(9):4862–4868
Weintraub SJ, Chow KN, Luo RX, Zhang SH, He S, Dean DC (1995) Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375(6534):812–815
Nielsen SJ, Schneider R, Bauer UM et al (2001) Rb targets histone H3 methylation and HP1 to promoters. Nature 412(6846): 561–565
Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T (1998) Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391(6667):597–601
Luo RX, Postigo AA, Dean DC (1998) Rb interacts with histone deacetylase to repress transcription. Cell 92(4):463–473
Magnaghi-Jaulin L, Groisman R, Naguibneva I et al (1998) Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391(6667):601–605
Lohmann DR, Gallie BL (2004) Retinoblastoma: revisiting the model prototype of inherited cancer. Am J Med Genet C Semin Med Genet 129C(1):23–28
Lohmann DR (1999) RB1 gene mutations in retinoblastoma. Hum Mutat 14(4):283–288
Frischmeyer PA, Dietz HC (1999) Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet 8(10):1893–1900
Sippel KC, Fraioli RE, Smith GD et al (1998) Frequency of somatic and germ-line mosaicism in retinoblastoma: implications for genetic counseling. Am J Hum Genet 62(3):610–619
Boerkoel CF, Exelbert R, Nicastri C et al (1995) Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II. Am J Hum Genet 56(4):887–897
Otterson GA, Chen W, Coxon AB, Khleif SN, Kaye FJ (1997) Incomplete penetrance of familial retinoblastoma linked to germ-line mutations that result in partial loss of RB function. Proc Natl Acad Sci USA 94(22):12036–12040
Dryja TP, Rapaport J, McGee TL, Nork TM, Schwartz TL (1993) Molecular etiology of low-penetrance retinoblastoma in two pedigrees. Am J Hum Genet 52(6):1122–1128
Windle JJ, Albert DM, O’Brien JM et al (1990) Retinoblastoma in transgenic mice. Nature 343(6259):665–669
Howes KA, Ransom N, Papermaster DS, Lasudry JG, Albert DM, Windle JJ (1994) Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes Dev 8(11):1300–1310
Robanus-Maandag E, Dekker M, van der Valk M et al (1998) p107 is a suppressor of retinoblastoma development in pRb-deficient mice. Genes Dev 12(11):1599–1609
Laurie NA, Donovan SL, Shih CS et al (2006) Inactivation of the p53 pathway in retinoblastoma. Nature 444(7115):61–66
Hahn WC, Weinberg RA (2002) Modelling the molecular circuitry of cancer. Nat Rev Cancer 2(5):331–341
Sherr CJ, McCormick F (2002) The RB and p53 pathways in cancer. Cancer Cell 2(2):103–112
Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they control. Nat Med 10(8):789–799
Kato MV, Shimizu T, Ishizaki K et al (1996) Loss of heterozygosity on chromosome 17 and mutation of the p53 gene in retinoblastoma. Cancer Lett 106(1):75–82
Nork TM, Poulsen GL, Millecchia LL, Jantz RG, Nickells RW (1997) p53 regulates apoptosis in human retinoblastoma. Arch Ophthalmol 115(2):213–219
Chen D, Livne-bar I, Vanderluit JL, Slack RS, Agochiya M, Bremner R (2004) Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma. Cancer Cell 5(6):539–551
Mukai S (2009) Retinoblastoma. In: Orkin SH, Fisher DE, Look AT, Lux S, Ginsburg D, Nathan DG (eds) Oncology of infancy and childhood, WB Saunders Co, Philadelphia
Halloran SL, Boughman JA, Dryja TP et al (1985) Accuracy of detection of the retinoblastoma gene by esterase D linkage. Arch Ophthalmol 103(9):1329–1331
Mukai S, Rapaport JM, Shields JA, Augsburger JJ, Dryja TP (1984) Linkage of genes for human esterase D and hereditary retinoblastoma. Am J Ophthalmol 97(6):681–685
Sparkes RS, Murphree AL, Lingua RW et al (1983) Gene for hereditary retinoblastoma assigned to human chromosome 13 by linkage to esterase D. Science 219(4587):971–973
Botstein D, White RL, Skolnick M, Davis RW (1980) Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am J Hum Genet 32(3):314–331
Cavenee WK, Dryja TP, Phillips RA et al (1983) Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305(5937):779–784
Dryja TP, Cavenee W, White R et al (1984) Homozygosity of chromosome 13 in retinoblastoma. N Engl J Med 310(9):550–553
Bookstein R, Lee EY, To H et al (1988) Human retinoblastoma susceptibility gene: genomic organization and analysis of heterozygous intragenic deletion mutants. Proc Natl Acad Sci USA 85(7):2210–2214
Dunn JM, Phillips RA, Becker AJ, Gallie BL (1988) Identification of germline and somatic mutations affecting the retinoblastoma gene. Science 241(4874):1797–1800
Horsthemke B, Barnert HJ, Greger V, Passarge E, Hopping W (1987) Early diagnosis in hereditary retinoblastoma by detection of molecular deletions at gene locus. Lancet 1(8531):511–512
Wiggs J, Nordenskjold M, Yandell D et al (1988) Prediction of the risk of hereditary retinoblastoma, using DNA polymorphisms within the retinoblastoma gene. N Engl J Med 318(3):151–157
Yandell DW, Campbell TA, Dayton SH et al (1989) Oncogenic point mutations in the human retinoblastoma gene: their application to genetic counseling. N Engl J Med 321(25):1689–1695
Yandell DW, Dryja TP (1989) Detection of DNA sequence polymorphisms by enzymatic amplification and direct genomic sequencing. Am J Hum Genet 45(4):547–555
Kleinerman RA, Tucker MA, Tarone RE et al (2005) Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol 23(10):2272–2279
Abramson DH (1985) Treatment of retinoblastoma. In: Blodi FC (ed) Contemporary issues in ophthalmology, vol. 2, retinoblastoma. Churchill Livingston, New York, pp 88–93
Munier FL, Thonney F, Girardet A et al (1998) Evidence of somatic and germinal mosaicism in pseudo-low-penetrant hereditary retinoblastoma, by constitutional and single-sperm mutation analysis. Am J Hum Genet 63(6):1903–1908
Connolly MJ, Payne RH, Johnson G et al (1983) Familial, EsD-linked, retinoblastoma with reduced penetrance and variable expressivity. Hum Genet 65(2):122–124
Macklin MT (1960) A study of retinoblastoma in Ohio. Am J Hum Genet 12:1–43
Strong LC, Riccardi VM, Ferrell RE, Sparkes RS (1981) Familial retinoblastoma and chromosome 13 deletion transmitted via an insertional translocation. Science 213(4515):1501–1503
Allderdice PW, Davis JG, Miller OJ et al (1969) The 13q-deletion syndrome. Am J Hum Genet 21(5):499–512
Seidman DJ, Shields JA, Augsburger JJ, Nelson LB, Lee ML, Sciorra LJ (1987) Early diagnosis of retinoblastoma based on dysmorphic features and karyotype analysis. Ophthalmology 94(6): 663–666
Rivera MN, Haber DA (2005) Wilms’ tumour: connecting tumorigenesis and organ development in the kidney. Nat Rev Cancer 5(9):699–712
Breslow N, Olshan A, Beckwith JB, Moksness J, Feigl P, Green D (1994) Ethnic variation in the incidence, diagnosis, prognosis, and follow-up of children with Wilms’ tumor. J Natl Cancer Inst 86(1):49–51
Stiller CA, Parkin DM (1990) International variations in the incidence of childhood renal tumours. Br J Cancer 62(6):1026–1030
National Cancer Institute (2004) Surveillance epidemiology and end results (SEER) pediatric monograph, National Cancer Institute, Bethesda, MD
Pastore G, Carli M, Lemerle J et al (1988) Epidemiological features of Wilms’ tumor: results of studies by the International Society of Paediatric Oncology (SIOP). Med Pediatr Oncol 16(1):7–11
Breslow N, Olshan A, Beckwith JB, Green DM (1993) Epidemiology of Wilms tumor. Med Pediatr Oncol 21(3):172–181
Daniels JL, Pan IJ, Olshan AF, Breslow NE, Bunin GR, Ross JA (2008) Obstetric history and birth characteristics and Wilms tumor: a report from the Children’s Oncology Group. Cancer Causes Control 19(10):1103–1110
Schuz J, Kaletsch U, Meinert R, Kaatsch P, Michaelis J (2001) High-birth weight and other risk factors for Wilms tumour: results of a population-based case-control study. Eur J Pediatr 160(6): 333–338
Olson JM, Breslow NE, Beckwith JB (1993) Wilms’ tumour and parental age: a report from the National Wilms’ Tumour Study. Br J Cancer 67(4):813–818
Cooney MA, Daniels JL, Ross JA, Breslow NE, Pollock BH, Olshan AF (2007) Household pesticides and the risk of Wilms tumor. Environ Health Perspect 115(1):134–137
Goel R, Olshan AF, Ross JA, Breslow NE, Pollock BH (2009) Maternal exposure to medical radiation and Wilms tumor in the offspring: a report from the Children’s Oncology Group. Cancer Causes Control 20(6):957–963
Jurewicz J, Hanke W (2006) Exposure to pesticides and childhood cancer risk: has there been any progress in epidemiological studies? Int J Occup Med Environ Health 19(3):152–169
Davidoff AM, Soutter AD, Shochat SJ (1998) Wilms tumor presenting with abdominal pain: a special subgroup of patients. Ann Surg Oncol 5(3):213–215
Maas MH, Cransberg K, van Grotel M, Pieters R, van den Heuvel-Eibrink MM (2007) Renin-induced hypertension in Wilms tumor patients. Pediatr Blood Cancer 48(5):500–503
Miller RW, Fraumeni JF Jr, Manning MD (1964) Association of Wilms’s tumor with aniridia, hemihypertrophy and other congenital malformations. N Engl J Med 270:922–927
Ng A, Griffiths A, Cole T et al (2007) Congenital abnormalities and clinical features associated with Wilms’ tumour: a comprehensive study from a centre serving a large population. Eur J Cancer 43(9):1422–1429
Dickson PV, Sims TL, Streck CJ et al (2008) Avoiding misdiagnosing neuroblastoma as Wilms tumor. J Pediatr Surg 43(6):1159–1163
Breslow N, Beckwith JB, Ciol M, Sharples K (1988) Age distribution of Wilms’ tumor: report from the National Wilms’ Tumor Study. Cancer Res 48(6):1653–1657
Dome JS, Cotton CA, Perlman EJ et al (2006) Treatment of anaplastic histology Wilms’ tumor: results from the fifth National Wilms’ Tumor Study. J Clin Oncol 24(15):2352–2358
Bardeesy N, Falkoff D, Petruzzi MJ et al (1994) Anaplastic Wilms’ tumour, a subtype displaying poor prognosis, harbours p53 gene mutations. Nat Genet 7(1):91–97
Bardeesy N, Beckwith JB, Pelletier J (1995) Clonal expansion and attenuated apoptosis in Wilms’ tumors are associated with p53 gene mutations. Cancer Res 55(2):215–219
Isaacs H Jr (2008) Fetal and neonatal renal tumors. J Pediatr Surg 43(9):1587–1595
Beckwith JB, Kiviat NB, Bonadio JF (1990) Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms’ tumor. Pediatr Pathol 10(1–2):1–36
Beckwith JB (1993) Precursor lesions of Wilms tumor: clinical and biological implications. Med Pediatr Oncol 21(3):158–168
Breslow NE, Olson J, Moksness J, Beckwith JB, Grundy P (1996) Familial Wilms’ tumor: a descriptive study. Med Pediatr Oncol 27(5):398–403
Knudson AG Jr, Strong LC (1975) Letter: Familial Wilms’s tumor. Am J Hum Genet 27(6):809–810
Li FP, Williams WR, Gimbrere K, Flamant F, Green DM, Meadows AT (1988) Heritable fraction of unilateral Wilms tumor. Pediatrics 81(1):147–149
Knudson AG Jr, Strong LC (1972) Mutation and cancer: a model for Wilms’ tumor of the kidney. J Natl Cancer Inst 48(2):313–324
Kreidberg JA, Sariola H, Loring JM et al (1993) WT-1 is required for early kidney development. Cell 74(4):679–691
Gessler M, Konig A, Arden K et al (1994) Infrequent mutation of the WT1 gene in 77 Wilms’ Tumors. Hum Mutat 3(3):212–222
Varanasi R, Bardeesy N, Ghahremani M et al (1994) Fine structure analysis of the WT1 gene in sporadic Wilms tumors. Proc Natl Acad Sci USA 91(9):3554–3558
Ton CC, Huff V, Call KM et al (1991) Smallest region of overlap in Wilms tumor deletions uniquely implicates an 11p13 zinc finger gene as the disease locus. Genomics 10(1):293–297
Riccardi VM, Sujansky E, Smith AC, Francke U (1978) Chromosomal imbalance in the Aniridia-Wilms’ tumor association: 11p interstitial deletion. Pediatrics 61(4):604–610
Fischbach BV, Trout KL, Lewis J, Luis CA, Sika M (2005) WAGR syndrome: a clinical review of 54 cases. Pediatrics 116(4): 984–988
Breslow NE, Norris R, Norkool PA et al (2003) Characteristics and outcomes of children with the Wilms tumor-Aniridia syndrome: a report from the National Wilms Tumor Study Group. J Clin Oncol 21(24):4579–4585
Xu S, Han JC, Morales A, Menzie CM, Williams K, Fan YS (2008) Characterization of 11p14-p12 deletion in WAGR syndrome by array CGH for identifying genes contributing to mental retardation and autism. Cytogenet Genome Res 122(2):181–187
Pelletier J, Bruening W, Kashtan CE et al (1991) Germline mutations in the Wilms’ tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67(2):437–447
Klamt B, Koziell A, Poulat F et al (1998) Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/−KTS splice isoforms. Hum Mol Genet 7(4):709–714
Barbaux S, Niaudet P, Gubler MC et al (1997) Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet 17(4):467–470
Li CM, Kim CE, Margolin AA et al (2004) CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms’ tumors. Am J Pathol 165(6):1943–1953
Koufos A, Grundy P, Morgan K et al (1989) Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5. Am J Hum Genet 44(5):711–719
Ping AJ, Reeve AE, Law DJ, Young MR, Boehnke M, Feinberg AP (1989) Genetic linkage of Beckwith-Wiedemann syndrome to 11p15. Am J Hum Genet 44(5):720–723
Waziri M, Patil SR, Hanson JW, Bartley JA (1983) Abnormality of chromosome 11 in patients with features of Beckwith-Wiedemann syndrome. J Pediatr 102(6):873–876
Pueschel SM, Padre-Mendoza T (1984) Chromosome 11 and Beckwith-Wiedemann syndrome. J Pediatr 104(3):484–485
Grundy PE, Telzerow PE, Breslow N, Moksness J, Huff V, Paterson MC (1994) Loss of heterozygosity for chromosomes 16q and 1p in Wilms’ tumors predicts an adverse outcome. Cancer Res 54(9):2331–2333
Wiedemann H-R (1983) Tumours and hemihypertrophy associated with Wiedemann-Beckwith syndrome (letter). Eur J Pediatr 141:129
Lapunzina P (2005) Risk of tumorigenesis in overgrowth syndromes: a comprehensive review. Am J Med Genet C Semin Med Genet 137C(1):53–71
Hao Y, Crenshaw T, Moulton T, Newcomb E, Tycko B (1993) Tumour-suppressor activity of H19 RNA. Nature 365(6448): 764–767
Scott RH, Douglas J, Baskcomb L et al (2008) Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor. Nat Genet 40(11): 1329–1334
Sparago A, Russo S, Cerrato F et al (2007) Mechanisms causing imprinting defects in familial Beckwith-Wiedemann syndrome with Wilms’ tumour. Hum Mol Genet 16(3):254–264
Feinberg AP, Williams BR (2003) Wilms’ tumor as a model for cancer biology. Methods Mol Biol 222:239–248
Cooper WN, Luharia A, Evans GA et al (2005) Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome. Eur J Hum Genet 13(9):1025–1032
Bliek J, Gicquel C, Maas S, Gaston V, Le Bouc Y, Mannens M (2004) Epigenotyping as a tool for the prediction of tumor risk and tumor type in patients with Beckwith-Wiedemann syndrome (BWS). J Pediatr 145(6):796–799
Weksberg R, Shuman C, Smith AC (2005) Beckwith-Wiedemann syndrome. Am J Med Genet C Semin Med Genet 137C(1):12–23
DeBaun MR, Niemitz EL, McNeil DE, Brandenburg SA, Lee MP, Feinberg AP (2002) Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am J Hum Genet 70(3):604–611
Lam WW, Hatada I, Ohishi S et al (1999) Analysis of germline CDKN1C (p57KIP2) mutations in familial and sporadic Beckwith-Wiedemann syndrome (BWS) provides a novel genotype-phenotype correlation. J Med Genet 36(7):518–523
Lee MP, DeBaun M, Randhawa G, Reichard BA, Elledge SJ, Feinberg AP (1997) Low frequency of p57KIP2 mutation in Beckwith-Wiedemann syndrome. Am J Hum Genet 61(2):304–309
Shuman C, Smith AC, Steele L et al (2006) Constitutional UPD for chromosome 11p15 in individuals with isolated hemihyperplasia is associated with high tumor risk and occurs following assisted reproductive technologies. Am J Med Genet A 140(14): 1497–1503
Rump P, Zeegers MP, van Essen AJ (2005) Tumor risk in Beckwith-Wiedemann syndrome: a review and meta-analysis. Am J Med Genet A 136(1):95–104
Weksberg R, Nishikawa J, Caluseriu O et al (2001) Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1. Hum Mol Genet 10(26): 2989–3000
Manipalviratn S, DeCherney A, Segars J (2009) Imprinting disorders and assisted reproductive technology. Fertil Steril 91(2): 305–315
Maw MA, Grundy PE, Millow LJ et al (1992) A third Wilms’ tumor locus on chromosome 16q. Cancer Res 52(11):3094–3098
Shearer PD, Valentine MB, Grundy P et al (1999) Hemizygous deletions of chromosome band 16q24 in Wilms tumor: detection by fluorescence in situ hybridization. Cancer Genet Cytogenet 115(2):100–105
Sheng WW, Soukup S, Bove K, Gotwals B, Lampkin B (1990) Chromosome analysis of 31 Wilms’ tumors. Cancer Res 50(9):2786–2793
Kondo K, Chilcote RR, Maurer HS, Rowley JD (1984) Chromosome abnormalities in tumor cells from patients with sporadic Wilms’ tumor. Cancer Res 44(11):5376–5381
Betts DR, Ilg EC, Oezahin H, von der Weid N, Niggli FK (1999) Trisomy 1q generating translocations in Wilms tumor. Cancer Genet Cytogenet 112(2):138–143
Messahel B, Williams R, Ridolfi A et al (2009) Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1-3 clinical trials: a Children’s Cancer and Leukaemia Group (CCLG) Study. Eur J Cancer 45(5):819–826
Grundy PE, Breslow NE, Li S et al (2005) Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol 23(29):7312–7321
Perotti D, De Vecchi G, Testi MA et al (2004) Germline mutations of the POU6F2 gene in Wilms tumors with loss of heterozygosity on chromosome 7p14. Hum Mutat 24(5):400–407
Perotti D, Testi MA, Mondini P et al (2001) Refinement within single yeast artificial chromosome clones of a minimal region commonly deleted on the short arm of chromosome 7 in Wilms tumours. Genes Chromosomes Cancer 31(1):42–47
Rivera MN, Kim WJ, Wells J et al (2007) An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. Science 315(5812):642–645
Perotti D, Gamba B, Sardella M et al (2008) Functional inactivation of the WTX gene is not a frequent event in Wilms’ tumors. Oncogene 27(33):4625–4632
Ruteshouser EC, Robinson SM, Huff V (2008) Wilms tumor genetics: mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors. Genes Chromosomes Cancer 47(6):461–470
Major MB, Camp ND, Berndt JD et al (2007) Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling. Science 316(5827):1043–1046
Chung NG, Kim MS, Chung YJ, Yoo NJ, Lee SH (2008) Tumor suppressor WTX gene mutation is rare in acute leukemias. Leuk Lymphoma 49(8):1616–1617
Yoo NJ, Kim S, Lee SH (2009) Mutational analysis of WTX gene in Wnt/ beta-catenin pathway in gastric, colorectal, and hepatocellular carcinomas. Dig Dis Sci 54(5):1011–1014
Owen C, Virappane P, Alikian M et al (2008) WTX is rarely mutated in acute myeloid leukemia. Haematologica 93(6):947–948
Virappane P, Gale R, Hills R et al (2008) Mutation of the Wilms’ tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: the United Kingdom Medical Research Council Adult Leukaemia Working Party. J Clin Oncol 26(33):5429–5435
Jenkins ZA, van Kogelenberg M, Morgan T et al (2009) Germline mutations in WTX cause a sclerosing skeletal dysplasia but do not predispose to tumorigenesis. Nat Genet 41(1):95–100
Rahman N, Arbour L, Tonin P et al (1996) Evidence for a familial Wilms’ tumour gene (FWT1) on chromosome 17q12-q21. Nat Genet 13(4):461–463
Rahman N, Abidi F, Ford D et al (1998) Confirmation of FWT1 as a Wilms’ tumour susceptibility gene and phenotypic characteristics of Wilms’ tumour attributable to FWT1. Hum Genet 103(5):547–556
Rahman N, Arbour L, Tonin P et al (1997) The familial Wilms’ tumour susceptibility gene, FWT1, may not be a tumour suppressor gene. Oncogene 14(25):3099–3102
McDonald JM, Douglass EC, Fisher R et al (1998) Linkage of familial Wilms’ tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors. Cancer Res 58(7):1387–1390
Huff V, Amos CI, Douglass EC et al (1997) Evidence for genetic heterogeneity in familial Wilms’ tumor. Cancer Res 57(10): 1859–1862
Hirsch B, Shimamura A, Moreau L et al (2004) Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood. Blood 103(7):2554–2559
Scott RH, Stiller CA, Walker L, Rahman N (2006) Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J Med Genet 43(9):705–715
Reid S, Renwick A, Seal S et al (2005) Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumour. J Med Genet 42(2):147–151
Xuan JY, Besner A, Ireland M, Hughes-Benzie RM, MacKenzie AE (1994) Mapping of Simpson-Golabi-Behmel syndrome to Xq25-q27. Hum Mol Genet 3(1):133–137
Neri G, Gurrieri F, Zanni G, Lin A (1998) Clinical and molecular aspects of the Simpson-Golabi-Behmel syndrome. Am J Med Genet 79(4):279–283
Pilia G, Hughes-Benzie RM, MacKenzie A et al (1996) Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat Genet 12(3):241–247
Lapunzina P, Badia I, Galoppo C et al (1998) A patient with Simpson-Golabi-Behmel syndrome and hepatocellular carcinoma. J Med Genet 35(2):153–156
Gillan TL, Hughes R, Godbout R, Grundy PE (2003) The Simpson-Golabi-Behmel gene, GPC3, is not involved in sporadic Wilms tumorigenesis. Am J Med Genet A 122A(1):30–36
Henneveld HT, van Lingen RA, Hamel BC, Stolte-Dijkstra I, van Essen AJ (1999) Perlman syndrome: four additional cases and review. Am J Med Genet 86(5):439–446
Alessandri JL, Cuillier F, Ramful D et al (2008) Perlman syndrome: report, prenatal findings and review. Am J Med Genet A 146A(19):2532–2537
Leventopoulos G, Kitsiou-Tzeli S, Kritikos K et al (2009) A clinical study of sotos syndrome patients with review of the literature. Pediatr Neurol 40(5):357–364
Tatton-Brown K, Rahman N (2007) Sotos syndrome. Eur J Hum Genet 15(3):264–271
Hanks S, Coleman K, Reid S et al (2004) Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat Genet 36(11):1159–1161
D’Angio GJ (2007) The National Wilms Tumor Study: a 40 year perspective. Lifetime Data Anal 13(4):463–470
Green DM, Breslow NE, Beckwith JB, Norkool P (1993) Screening of children with hemihypertrophy, aniridia, and Beckwith-Wiedemann syndrome in patients with Wilms tumor: a report from the National Wilms Tumor Study. Med Pediatr Oncol 21(3):188–192
McNeil DE, Langer JC, Choyke P, DeBaun MR (2002) Feasibility of partial nephrectomy for Wilms’ tumor in children with Beckwith-Wiedemann syndrome who have been screened with abdominal ultrasonography. J Pediatr Surg 37(1):57–60
Beckwith JB (1998) Children at increased risk for Wilms tumor: monitoring issues. J Pediatr 132(3 Pt 1):377–379
Coppes MJ, Arnold M, Beckwith JB et al (1999) Factors affecting the risk of contralateral Wilms tumor development: a report from the National Wilms Tumor Study Group. Cancer 85(7): 1616–1625
Choyke PL, Siegel MJ, Craft AW, Green DM, DeBaun MR (1999) Screening for Wilms tumor in children with Beckwith-Wiedemann syndrome or idiopathic hemihypertrophy. Med Pediatr Oncol 32(3):196–200
Surveillance, Epidemiology, and End Results (SEER) Program (2001) Public Use Data (1973–1998), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, Bethesda, MD
Gronskov K, Olsen JH, Sand A et al (2001) Population-based risk estimates of Wilms tumor in sporadic aniridia. A comprehensive mutation screening procedure of PAX6 identifies 80% of mutations in aniridia. Hum Genet 109(1):11–18
Craft AW, Parker L, Stiller C, Cole M (1995) Screening for Wilms’ tumour in patients with aniridia, Beckwith syndrome, or hemihypertrophy. Med Pediatr Oncol 24(4):231–234
Scott RH, Walker L, Olsen OE et al (2006) Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice. Arch Dis Child 91(12):995–999
Niemitz EL, Feinberg AP, Brandenburg SA, Grundy PE, DeBaun MR (2005) Children with idiopathic hemihypertrophy and beckwith-wiedemann syndrome have different constitutional epigenotypes associated with wilms tumor. Am J Hum Genet 77(5): 887–891
Gylys-Morin V, Hoffer FA, Kozakewich H, Shamberger RC (1993) Wilms tumor and nephroblastomatosis: imaging characteristics at gadolinium-enhanced MR imaging. Radiology 188(2):517–521
Choyke PL, Siegel MJ, Oz O, Sotelo-Avila C, DeBaun MR (1998) Nonmalignant renal disease in pediatric patients with Beckwith-Wiedemann syndrome. AJR Am J Roentgenol 171(3):733–737
Han JW, Kwon SY, Won SC, Shin YJ, Ko JH, Lyu CJ (2009) Comprehensive clinical follow-up of late effects in childhood cancer survivors shows the need for early and well-timed intervention. Ann Oncol 20(7):1170–1177
Cotton CA, Peterson S, Norkool PA, Takashima J, Grigoriev Y, Breslow NE (2009) Early and late mortality after diagnosis of Wilms’ tumor. J Clin Oncol 27(8):1304–1309
Shaw NJ, Eden OB, Jenney ME et al (1991) Pulmonary function in survivors of Wilms’ tumor. Pediatr Hematol Oncol 8(2):131–137
Green DM, Peabody EM, Nan B, Peterson S, Kalapurakal JA, Breslow NE (2002) Pregnancy outcome after treatment for Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol 20(10):2506–2513
Byrne J, Mulvihill JJ, Connelly RR et al (1988) Reproductive problems and birth defects in survivors of Wilms’ tumor and their relatives. Med Pediatr Oncol 16(4):233–240
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Sweetser, D.A., Grabowski, E.F. (2010). Pediatric Malignancies: Retinoblastoma and Wilms’ Tumor. In: Chung, D., Haber, D. (eds) Principles of Clinical Cancer Genetics. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-93846-2_12
Download citation
DOI: https://doi.org/10.1007/978-0-387-93846-2_12
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-93844-8
Online ISBN: 978-0-387-93846-2
eBook Packages: MedicineMedicine (R0)